AltheRx Pharmaceuticals lands $15 million, new board and CEO

Comment icon 0 Comments
You never know when an acquisition involving the automobile industry in the Midwest in 1998 might affect a drug-development firm in the Philadelphia... Read more

Shire buys SARcode Bioscience for at least $160 million

Comment icon 0 Comments
Shire P.L.C. will buy SARcode Bioscience Inc., which is developing a treatment for dry eyes, in a deal worth at least $160 million. The pharmaceutical... Read more

AmerisourceBergen shares rise 7 pct. on Walgreens deal

Comment icon 0 Comments
Shares of AmerisourceBergen Corp. were up 7 percent Tuesday morning after the pharmaceutical wholesaler signed long-term deals to supply Walgreen... Read more

Discovery Labs to launch Surfaxin in 2nd quarter

Comment icon 0 Comments
More than a year after receiving regulatory approval for its first drug, Discovery Laboratories Inc. still has not launched Surfaxin, a treatment... Read more

Biotechnology center bustles with start-ups in Bucks County

Comment icon 0 Comments
I am no fan of economic-impact studies because, while written by third-party economists, they are usually paid for by organizations who want... Read more

BioClinica to be bought by private-equity firm JLL for $123 million

Comment icon 0 Comments
BioClinica Inc., a Bucks County-based provider of clinical trial management services, will be acquired by JLL Partners Inc., a New York private-equity... Read more

Delaware incentives for Incyte amount to $18,000 per job

Comment icon 0 Comments
One factoid that didn't make it into my column in Wednesday's newspaper on state subsidies to corporations, which focused on Delaware's $11... Read more

Takeda to sell non-gout drug URL businesses to Caraco for $65 million

Comment icon 0 Comments
An update to my column in Tuesday's paper about the mix of messages emerging from several of the region's life-sciences firms: A spokeswoman... Read more